Business Description
![Prestige Consumer Healthcare Inc Prestige Consumer Healthcare Inc logo](https://static.gurufocus.com/logos/0C000008KY.png?14)
Prestige Consumer Healthcare Inc
NAICS : 325412
SIC : 2834
ISIN : US74112D1019
Description
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.04 | |||||
Equity-to-Asset | 0.5 | |||||
Debt-to-Equity | 0.69 | |||||
Debt-to-EBITDA | 3.05 | |||||
Interest Coverage | 5.1 | |||||
Piotroski F-Score | 8/9 | |||||
Altman Z-Score | 2.5 | |||||
Beneish M-Score | -2.43 | |||||
WACC vs ROIC |
Growth Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 6.4 | |||||
3-Year EBITDA Growth Rate | 6 | |||||
3-Year EPS without NRI Growth Rate | 6.5 | |||||
3-Year FCF Growth Rate | 4.2 | |||||
3-Year Book Growth Rate | 6.9 | |||||
Future 3-5Y EPS without NRI Growth Rate | 6.94 | |||||
Future 3-5Y Total Revenue Growth Rate | 1.74 |
Momentum Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 34.74 | |||||
9-Day RSI | 40.04 | |||||
14-Day RSI | 40.33 | |||||
6-1 Month Momentum % | 17.22 | |||||
12-1 Month Momentum % | 24.69 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.2 | |||||
Quick Ratio | 2.02 | |||||
Cash Ratio | 0.4 | |||||
Days Inventory | 113.76 | |||||
Days Sales Outstanding | 55.73 | |||||
Days Payable | 35.46 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 0.1 | |||||
Shareholder Yield % | 7.1 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 55.49 | |||||
Operating Margin % | 30.43 | |||||
Net Margin % | 18.6 | |||||
FCF Margin % | 21.27 | |||||
ROE % | 13.56 | |||||
ROA % | 6.27 | |||||
ROIC % | 8.21 | |||||
ROC (Joel Greenblatt) % | 116.15 | |||||
ROCE % | 10.72 | |||||
Years of Profitability over Past 10-Year | 8 |
GF Value Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 15.57 | |||||
Forward PE Ratio | 14.66 | |||||
PE Ratio without NRI | 15.43 | |||||
Shiller PE Ratio | 23.45 | |||||
Price-to-Owner-Earnings | 15.46 | |||||
PS Ratio | 2.88 | |||||
PB Ratio | 1.95 | |||||
Price-to-Free-Cash-Flow | 13.62 | |||||
Price-to-Operating-Cash-Flow | 13.09 | |||||
EV-to-EBIT | 12.53 | |||||
EV-to-Forward-EBIT | 12.51 | |||||
EV-to-EBITDA | 11.5 | |||||
EV-to-Forward-EBITDA | 11.59 | |||||
EV-to-Revenue | 3.82 | |||||
EV-to-Forward-Revenue | 3.8 | |||||
EV-to-FCF | 17.96 | |||||
Price-to-Projected-FCF | 0.96 | |||||
Price-to-Median-PS-Value | 1.05 | |||||
Earnings Yield (Greenblatt) % | 7.98 | |||||
FCF Yield % | 7.38 | |||||
Forward Rate of Return (Yacktman) % | -23.49 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:PBH
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Prestige Consumer Healthcare Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 1,125.357 | ||
EPS (TTM) ($) | 4.17 | ||
Beta | 0.48 | ||
Volatility % | 25.08 | ||
14-Day RSI | 40.33 | ||
14-Day ATR ($) | 1.472389 | ||
20-Day SMA ($) | 64.538 | ||
12-1 Month Momentum % | 24.69 | ||
52-Week Range ($) | 56.25 - 75.31 | ||
Shares Outstanding (Mil) | 49.92 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 8 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Prestige Consumer Healthcare Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Prestige Consumer Healthcare Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Prestige Consumer Healthcare Inc Frequently Asked Questions
What is Prestige Consumer Healthcare Inc(PBH)'s stock price today?
The current price of PBH is $64.94. The 52 week high of PBH is $75.31 and 52 week low is $56.25.
When is next earnings date of Prestige Consumer Healthcare Inc(PBH)?
The next earnings date of Prestige Consumer Healthcare Inc(PBH) is 2024-08-02 Est..
Does Prestige Consumer Healthcare Inc(PBH) pay dividends? If so, how much?
Prestige Consumer Healthcare Inc(PBH) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |